CRYSTAL GREGORY: Open Payments
NPI 1174550958 · BELINGTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 26 payments from 7 companies in 2025. Trend: 2023 $132 · 2024 $585 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $142 |
| ABBVIE INC. | 6 | $114 |
| PFIZER INC. | 4 | $84 |
| AstraZeneca Pharmaceuticals LP | 4 | $61 |
| Lilly USA, LLC | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: Ozempic, UBRELVY, ELIQUIS, Rybelsus, XIFAXAN, QULIPTA, BREZTRI, PREVNAR 20.
Industry payments across WV — which companies pay providers there.
